Research firm GoodFirms said on Thursday that the hospitals are adapting various healthcare software to maintain and manage the records to reduce the viral transmission between patients and providers via the exchange of files or prescriptions during the COVID-19 crisis.
In the face of COVID-19, most healthcare departments, pharmacy companies and medical practice institutes have invested in software to keep the information confidential and secure and make it easier to get the data in just one click.
However, various health professionals and healthcare facility providers are facing challenges to pick the right tool. Therefore, GoodFirms.co has evaluated a list of Medical Practice Management, Medical Transcription, Mental Health, Chiropractic, Child Care, Dental Practice, Electronic Medical Records and Hospital Management Software.
The firm is providing Best Medical Practice Management Software, Best Medical Transcription Software, Best Mental Health Software, Best Chiropractic Management Software, Best Child Care Software, Best Dental Practice Software, Best Electronic Medical Records Software as well as Best Hospital Management Software to increase productivity and earn more revenue during the pandemic.
Assembly Biosciences reports positive interim Phase 1b data for herpes treatment candidate ABI-5366
Dubai Culture and Zayed University Invite Global Creatives to Participate in ISEA2026
VolitionRx proposes underwritten public offering of common stock and common stock warrants
Celltrion's biosimilar EYDENZELT (aflibercept-boav) approved by US FDA
WuXi Biologics recognised with MSCI AAA ESG rating for third consecutive year
Tempus selected by ARPA-H to provide CRO and testing services for ADAPT cancer programme
Novo Nordisk to acquire Akero Therapeutics in USD5.2bn deal to strengthen MASH pipeline
Zelluna receives positive MHRA feedback and advances UK clinical plans for ZI-MA4-1
C-Ray Therapeutics (Shanghai) presents 225Ac-PSMA-CY313 breakthrough clinical data at EANM 2025
Astellas to present new data on IZERVAY in geographic atrophy data at AAO 2025
TransCode acquires Polynoma and secures USD25m investment from CK Life Sciences
Rigel Pharmaceuticals begins dose expansion phase of R289 study in lower-risk MDS